No title
Selective Serotonin Reuptake Inhibitors (SSRIs) may reach effect concentrations in aquatic environments and disrupt serotonergic signalling in non-target invertebrates, yet mechanistic understanding remains limited. This study aimed to 1) explore the measurability of a key event associated with serotonin reuptake inhibition within a putative Adverse Outcome Pathway for SSRIs, 2) evaluate the feasi
